MDS Pharma Services provides a full range of generic drug development
services, which are available individually or collectively to meet your needs. Our
staff stands at the forefront of all issues that affect the drug development and
approval process for generics.
For your next bioequivalence program, MDS Pharma Services will help get your
product to market faster. We offer global clinical capacity, on-time recruitment
capabilities, proactive study design and assay development programs—all of
which mean faster study start-up for you.
Our extensive expertise in study design
and worldwide regulatory knowledge, together with a comprehensive range of
services, helps speed your bioequivalence program through any approval
process. Our team of generic drug development professionals will assist you in
getting your bioequivalence study approved and your product ready for market.
